| Bioactivity | BNC105P is a phosphate prodrug of BNC105 (HY-16114), that exhibits activity as a vascular disrupting agent (VDA) and an antitumor agent through conversion to active BNC105[1]. |
| CAS | 945771-96-0 |
| Formula | C20H19Na2O10P |
| Molar Mass | 496.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rischin D, et al., Clinical, pharmacodynamic, and pharmacokinetic evaluation of BNC105P: a phase I trial of a novel vascular disrupting agent and inhibitor of cancer cell proliferation. Clin Cancer Res. 2011 Aug 1;17(15):5152-60. |
BNC105P
CAS: 945771-96-0 F: C20H19Na2O10P W: 496.31
BNC105P is a phosphate prodrug of BNC105 (HY-16114), that exhibits activity as a vascular disrupting agent (VDA) and an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.